---
schema_version: "secwatch.filing_event.v1"
accession: "0001077183-26-000029"
form_type: "8-K"
ticker: "NEO"
cik: "0001077183"
company_name: "NEOGENOMICS INC"
filed_at: "2026-06-15T21:24:55+00:00"
generated_at: "2026-06-15T21:26:19.723737+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# NeoGenomics commences $275M convertible note offering due 2032

## Summary
- Offering $275M aggregate principal amount of convertible senior notes due 2032, with option for additional $41.25M.
- Notes offered to qualified institutional buyers under Rule 144A; interest rate and conversion rate set at pricing.
- Proceeds used to repurchase a portion of existing 0.25% convertible notes due 2028 and up to $25M of common stock.
- Company to enter capped call transactions to reduce potential dilution upon conversion.
- The offering is contingent on market conditions and not registered under the Securities Act.

## SEC filing metadata
- accession: 0001077183-26-000029
- form_type: 8-K
- ticker: NEO
- cik: 0001077183
- company_name: NEOGENOMICS INC
- filed_at: 2026-06-15T21:24:55+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000029/0001077183-26-000029-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1077183/000107718326000029/neo-20260615.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001077183-26-000029
- JSON: https://secwatch.observer/filing/0001077183-26-000029.json
- Plain text: https://secwatch.observer/filing/0001077183-26-000029.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.